TL-03

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTL-03
Drug Alias NameTL-03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulantsAnti-TGF-β
TargetsTransforming growth factor beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTilos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTilos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A